In the current study, we found that silencing of GPER1 inhibited the EMT by upregulating E-cadherin and downregulating N-cadherin and vimentin, resulting in a decline in the migration and invasion of gastric cancer cell lines. The gene discussed is CDH2; the disease is gastric cancer.